Abreos Biosciences: Abreos Biosciences Launches Laboratory Developed Test for Precision Dose Monitoring of Natalizumab Tysabri

Novel assay addresses substantial unmet need for physicians to more effectively monitor biologic drug levels in patients.SAN DIEGO PRWEB August 22 2018 Abreos Biosciences a San Diegobased biotech company and leader in the precision dosing of biological th...